The Claim
The claim is that ordinary exposure to 5G phones, base stations or small cells causes cancer.
That sounds like one question, but “5G exposure” covers different frequencies and geometries: a phone transmitting against the body is not the same exposure as a distant base station, and mid-band 5G is not the same as millimetre-wave 5G.
The useful question is therefore: has real-world 5G exposure been shown to cause cancer, and what can the broader radiofrequency (RF) evidence legitimately tell us?
Where It Comes From
5G arrived on top of a long-running debate about radiofrequency electromagnetic fields from mobile phones, broadcast systems and Wi-Fi.
It also introduced features that sound novel: new frequency bands, beamforming and denser infrastructure. At the same time, IARC’s existing classification of RF-EMF is Group 2B: possibly carcinogenic to humans, and experimental-animal studies have reported tumours under some RF exposure conditions.
Those facts justify investigation. They do not establish the specific 5G claim.
Why It Sounds Convincing
“Higher frequency” can sound like “more dangerous radiation.” But frequency, photon energy, penetration depth, field strength, duty cycle and absorbed power are separate quantities.
Even millimetre-wave 5G remains non-ionizing; individual photons do not have enough energy to ionize DNA the way X-rays can. At higher RF frequencies, absorption also becomes more superficial.
That rules out one familiar carcinogenic mechanism. It does not prove that every non-ionizing exposure is biologically irrelevant.
The Short Answer
Ordinary exposure to 5G networks has not been shown to cause cancer.
Most long-term human research concerns earlier mobile-phone technologies, because 5G has not been in widespread use long enough for decades of direct cancer follow-up. The broader human evidence has not established an increased risk for the best-studied tumors, but it cannot settle every question about lifelong 5G exposure.
Some controlled animal experiments found tumors after much higher whole-body radiofrequency exposures than people typically receive. Researchers disagree about how confidently those findings can be generalized. The conclusion is not that every conceivable RF risk has been ruled out: it is that cancer from ordinary 5G exposure has not been demonstrated.
How It Would Have to Work
A meaningful 5G cancer effect should connect realistic exposure to a reproducible carcinogenic process and, eventually, to a human population signal.
That requires well-characterized dose, biologically plausible effects at those doses, and higher cancer incidence among more-exposed populations after appropriate latency and confounder control.
Because widespread 5G deployment began only around 2019, the long-latency part of that chain is still immature.
What Actually Happens
5G is a technology, not one frequency
5G networks use several frequency bands. Their radio waves are non-ionizing: unlike X-rays, individual RF photons do not carry enough energy to directly break chemical bonds in DNA. That does not settle every possible biological question, but any proposed cancer mechanism must be tested rather than assumed.
Antennas can direct signals toward connected devices, so actual exposure depends on the location, network traffic and whether a person’s own phone is actively transmitting.
Researchers can measure exposure, but that is not the same as measuring cancer
A 2025 European measurement campaign recorded radiofrequency levels across hundreds of everyday locations, including in Poland. The observed levels were below the reference limits used by the investigators. The equipment covered the lower frequency bands in use, not every higher-frequency 5G deployment, and measured signals from multiple wireless services.
Such measurements tell us about exposure under those conditions. They do not follow people for decades or prove that a particular exposure can never carry a cancer risk.
What the Evidence Shows
What studies of people tell us
Researchers have followed mobile-phone users and compared cancer diagnoses among people with different histories of phone use. A large European prospective study, COSMOS, did not find a convincing increase in the main brain tumors investigated. It mainly reflects earlier mobile technologies, not lifetime 5G exposure.
An older international study, INTERPHONE, reported an increased glioma association among people who recalled the heaviest lifetime phone use. That finding matters and should not be erased. But it came from a subgroup relying on recollection of past use, and the study also had other results that made the overall pattern difficult to interpret. Later reviews and published methodological responses have disagreed about how much weight to give such evidence.
The broad human picture is therefore not a reproducible cancer increase in the best-studied mobile-phone outcomes, with real uncertainty for some questions—especially long-term, specifically 5G exposures and less-studied tumors.
What the animal experiments tell us
In a major US National Toxicology Program experiment, researchers exposed rats to radiofrequency signals over much of their bodies for long periods. At some of the higher exposures, male rats developed more of a rare type of heart tumor than unexposed controls. This is a genuine experimental finding relevant to possible RF hazards.
Research groups in Korea and Japan later conducted new long-term rat experiments at a different, lower experimental dose and did not establish the same clear tumor increase. Those studies also had limitations: rare tumors are difficult to study in small animal groups, and testing one dose cannot settle all exposure patterns. Their results do not simply cancel the earlier positive experiment.
Reviews of the animal research have reached different judgments about how certain the evidence is. A formally corrected review still considers some heart and brain tumor findings strong under its assessment method; a separate quantitative reanalysis assigns lower certainty, particularly for brain tumors. The assessments draw on overlapping animal experiments, not independent new sets of laboratory animals. Their disagreement concerns the strength of the inference; neither justifies pretending the positive findings never occurred.
Crucially, high experimental whole-body exposures in rats are not the same as ordinary exposure to 5G infrastructure or a phone. Differences in absorbed energy, duration, species and signal characteristics matter when considering human risk.
What about higher 5G frequencies?
Evidence for everyday exposures in the higher-frequency bands is more limited. Researchers have studied some biological responses, but there is not yet a decades-long, 5G-specific human cancer record. Missing long-term data are a limitation, not evidence that cancer is occurring.
Taken together, the evidence supports continued exposure measurement and research while leaving the specific claim that ordinary 5G networks cause cancer unsubstantiated.
The Strongest Evidence for the Claim
The strongest serious reasons for concern are positive tumor findings in some animal RF experiments, an older subgroup finding in heavy mobile-phone users, and the absence of long-term human follow-up specifically for 5G. Radiofrequency fields have also been classified by IARC as possibly carcinogenic, a hazard classification that does not establish a cancer risk from every everyday exposure.
These findings justify continued investigation. They do not show that ordinary 5G networks have caused human cancers.
The Strongest Evidence Against It
The strongest counter-evidence comes from the wider human mobile-phone research, which has not shown a consistent cancer increase for the best-studied tumors, together with measurements showing that everyday network exposures in studied environments are generally far below reference limits.
These are related but not identical lines of evidence: earlier phones are not lifelong 5G exposure, and being below a limit is not a substitute for a cancer study. The current evidence does not support the ordinary-exposure claim, but the conclusion should not be inflated into proof of zero risk under every circumstance.
Common Viral Arguments
“5G uses higher frequencies, so it must be more dangerous.”
Higher frequency changes wavelength, penetration and absorption. Risk also depends on power, duration, geometry and absorbed dose.
“There are no long-term 5G studies.”
Correct. That is a limitation of a recent technology, not evidence that cancer is occurring.
“IARC says RF is carcinogenic.”
IARC’s current category is possibly carcinogenic to humans (Group 2B). It is a hazard classification, not a numerical risk estimate for a 5G phone or tower.
“Animal studies prove 5G causes tumours.”
They are broader RF experiments under specific laboratory exposures, not direct ordinary-5G studies in people. Their evidentiary strength is also methodologically disputed.
“Below the legal limit means safe.”
Compliance is useful exposure context. It is not independent proof of zero risk.
The Reasoning Error
The main error is hazard-risk confusion: evidence that RF can cause harm under some condition is treated as though it directly quantifies risk from a specific 5G exposure.
A second is dose neglect, which treats a laboratory whole-body exposure, a phone against the body and a distant antenna as interchangeable.
A third is the category error of importing the mechanisms of ionizing radiation into non-ionizing RF without demonstrating the same causal pathway.
What Would Change Our Conclusion?
The conclusion would change if well-designed human studies with measured 5G exposure found a reproducible cancer increase with appropriate latency and dose-response characteristics.
Replicated animal and mechanistic effects at exposure patterns closely matching ordinary 5G would also strengthen the case. Strong long-term 5G-specific cohorts with consistently null results would increase confidence in the opposite direction.
Evidence Status
Status: Unsupported
Evidence quality: Moderate
The available evidence does not demonstrate that ordinary 5G exposure causes cancer. Broader RF research contains genuine hazard signals and unresolved questions, but those do not establish the specific real-world 5G claim.
Sources
The evidence trail includes WHO/IARC material, human RF cancer systematic reviews, the corrected animal review and its published methodological critique, above-6-GHz research and direct measurements of modern 5G exposure.
Corrections & Updates
October 9, 2026 — evidence clarification. Expanded the source-specific human tumour discussion with COSMOS denominators, confidence intervals and its non-5G exposure design. Added measurement conditions and the 6-GHz upper limit of the 2025 European RF survey. The Unsupported / Moderate conclusion is unchanged.
Last Reviewed
October 9, 2026.